期刊文献+

2型猪链球菌疫苗候选分子的研究进展 被引量:1

Research Advance on Vaccine Candidates against Streptococcus suis Serotype 2
原文传递
导出
摘要 猪链球菌是一种全球性严重人兽共患病病原体,因为缺乏有效疫苗,使感染难以控制。目前疫苗研究主要集中在血清2型,因其流行范围最广。猪链球菌疫苗研究的方法包括构建基因表达文库、免疫蛋白质组学方法、反向疫苗学方法和其它传统方法。本文对目前为止所识别和评价的猪链球菌2型疫苗候选分子进行综述,包括全菌疫苗、荚膜多糖、蛋白抗原。其中很多疫苗候选分子对小鼠或者猪有保护效果,而要获得针对更多血清型的通用疫苗则需要更多努力。 Streptococcus suis infection is an important zoonotic disease world widely suffered, and attempts to control the infection are hampered by the lack of an effective vaccine. Studies on vaccines have focused on Streptococcus suis serotype 2, the most prevalent type associated with diseases in most countries. There are many approaches to develop vaccine candidates against the pathogenic bacteria including construction of expression protein library, immunoproteomics, reverse vaccinology, and other traditional method. In this review, different types of recent vaccine candidates are discussed, such as bacterin, capsular polysaccharide, and protein antigens, most of which are protective for mice or pigs, while the development of a general vaccine against more serotypes needs further effort.
出处 《现代生物医学进展》 CAS 2009年第14期2798-2800,共3页 Progress in Modern Biomedicine
基金 国家863课题(No.2006AA02Z404)
关键词 猪链球菌 疫苗 血清2型 保护性抗原 Streptococcus suis Vaccine Serotype 2 Protective antigens
  • 相关文献

参考文献27

  • 1Yu H, Jing H, Chen Z et al. Human Streptococcus suis outbreak, Sichuan, China [J]. Emerg Infect Dis, 2006, 12(6): 914-20.
  • 2Sriskandan S, Slater JD. Invasive disease and toxic shock due to zoonotic Streptococcus suis: an emerging infection in the East [J]. PLoS Med, 2006, 3(5): e 187.
  • 3Holt ME, Enright MR, Alexander TJ. Immunisation of pigs with killed cultures of Streptococcus suis type 2[J]. Res Vet Sci, 1990, 48(1):23-7.
  • 4Foster N, Staats J J, Chengappa MM. Isolation, characterization and protection studies in mice of a streptomycin-dependent mutant of Streptococcus suis type 1/2[J]. Vet Res Commun, 1994, 18(3):155-63.
  • 5Kebede M, Chengappa MM, Stuart JG. Isolation and characterization of temperature-sensitive mutants of Streptococcus suis: efficacy trial of the mutant vaccine in mice [J]. Vet Microbiol, 1990, 22(2-3): 249-57.
  • 6Pallares FJ, Schmitt CS, Roth JA et al. Evaluation of a ceftiofur-washed whole cell Streptococcus suis bacterin in pigs [J]. Can J Vet Res, 2004, 68(3):236-40.
  • 7Fittipaldi N, Harel J, D'Amours Bet al. Potential use of an unencapsulated and aromatic amino acid-auxotrophic Streptococcus suis mutant as a live attenuated vaccine in swine [J]. Vaccine, 2007, 25 (18): 3524-35.
  • 8Elliott SD, Clifton-Hadley F, Tai J. Streptococcal infection in young pigs. V. An immunogenic polysaccharide from Streptococcus suis type 2 with particular reference to vaccination against streptococcal meningitis in pigs [J]. J Hyg (Lond), 1980, 85(2):275-85.
  • 9Baums CG, Kock C, Beineke Aet al. Streptococcus suis bacterin and subunit vaccine immunogenicities and protective etticacies against serotypes 2 and 9 [J]. Clin Vaccine Immunol, 2009, 16(2): 200-8.
  • 10Vecht U, Wisselink HJ, Jellema ML, Smith HE. Identification of two proteins associated with virulence of Streptococcus suis type2 [J]. Infect Immun, 1991, 59(9): 3156-62.

同被引文献15

  • 1王华,赵云玲,王君玮,王志亮,陈义平.猪链球菌病流行病学及其疫苗研究现状[J].动物医学进展,2006,27(9):27-31. 被引量:23
  • 2王海燕,刘铭,王化军,曹竹安.乳酸生产中的微生物代谢工程[J].过程工程学报,2006,6(3):512-516. 被引量:14
  • 3Dekker C N T,Bouma A,Daemen AJJ M,et al.Homologous whole bacterin vaccination is not able to reduce Streptococcus suis serotype 9 strain 7997 transmission among pigs or coloni- zation[J],Vaccine,2012,30:1379-1387.
  • 4Zhu H D,Huang D Y,Zhang W,et al.The novel virulence-re- lated gene stp of Streptococcus suis serotype 9 strain contrib- utes to a significant reduction in mouse mortality[J],Microbial Pathogenesis,2011,51:442-453.
  • 5Higgins R,Gottschalk M,Boudreau M,et al.Description of six new capsular types(29-34)of Streptococcus suis[J].J Vet Di- agn Invest,1995,7(3):405-406.
  • 6Yu H,Jing H,Chen Z,et al.Human Streptococcus suis outbre- ak,Sichuan,China[J].Emerg Infect Dis,2006,12(6):914-920.
  • 7Li J Q,Xia J,Tan C.Evaluation of the immunogenicity and the protective efficacy of a novel identified immunogenic protein,SsPepO,of Streptococcus suis serotype 2[J].Vaccine,2011,29:6514-6519.
  • 8Zhang W,Lu C P.Immunoproteomics of extracellular proteins of Chinese virulent strains of Streptococcus suis type 2[J].Proteomics,2007,7:4468-4476.
  • 9Du H M,Huang W,Xie H F,et al.The genetically modified suilysin,rSLY P353L,provides a candidate vaccine that sup- presses proinflammatory response and reduces fatality follow- ing infection with Streptococcus suis[J].Vaccine,2013,31:4209-4215.
  • 10Kao S M,Miller E D,Su L.A leucine zipper motif in the cyto- plasmic domain of gp41 is required for HIV21 replication and pathogenesis[J].Virology,2001,289:208-217.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部